An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis

Background and Aims Cholesterol gallstone disease is a complex process involving both genetic and environmental variables. No information exists regarding what role if any the indigenous gastrointestinal microbiota may play in cholesterol gallstone pathogenesis and whether variations in the microbiota can alter cholesterol gallstone prevalence rates. Methods Genetically related substrains (BALB/cJ and BALB/cJBomTac) and (BALB/AnNTac and BALB/cByJ) of mice obtained from different vendors were compared for cholesterol gallstone prevalence after being fed a lithogenic diet for 8 weeks. The indigenous microbiome was altered in these substrains by oral gavage of fecal slurries as adults, by cross-fostering to mice with divergent flora at <1day of age or by rederiving into a germ-free state. Results Alterations in the indigenous microbiome altered significantly the accumulation of mucin gel and normalized gallbladder weight but did not alter cholesterol gallstone susceptibility in conventionally housed SPF mice. Germ-free rederivation rendered mice more susceptible to cholesterol gallstone formation. This susceptibility appeared to be largely due to alterations in gallbladder size and gallbladder wall inflammation. Colonization of germ-free mice with members of altered Schaedler flora normalized the gallstone phenotype to a level similar to conventionally housed mice. Conclusions These data demonstrate that alterations in the gastrointestinal microbiome may alter aspects of cholesterol gallstone pathogenesis and that in the appropriate circumstances these changes may impact cholesterol cholelithogenesis.

[1]  J. Behar,et al.  Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: cholecystitis is not caused by cystic duct obstruction , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[3]  J B L Hoekstra,et al.  The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus , 2012, Diabetes, obesity & metabolism.

[4]  M. Potter The BALB/c mouse. Genetics and immunology. , 2011, Current topics in microbiology and immunology.

[5]  Nathalie M. Delzenne,et al.  Targeting gut microbiota in obesity: effects of prebiotics and probiotics , 2011, Nature Reviews Endocrinology.

[6]  J. Alverdy,et al.  Contributions of intestinal bacteria to nutrition and metabolism in the critically ill. , 2011, The Surgical clinics of North America.

[7]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[8]  J. Versalovic,et al.  Lactobacillus reuteri promotes Helicobacter hepaticus‐associated typhlocolitis in gnotobiotic B6.129P2‐IL‐10tm1Cgn (IL‐10−/−) mice , 2011, Immunology.

[9]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[10]  K. Erpecum,et al.  Pathogenesis of cholesterol and pigment gallstones: an update. , 2011, Clinics and research in hepatology and gastroenterology.

[11]  H. Wittenburg Hereditary liver disease: gallstones. , 2010, Best practice & research. Clinical gastroenterology.

[12]  F. Bäckhed,et al.  Coordinated regulation of the metabolome and lipidome at the host-microbial interface. , 2010, Biochimica et biophysica acta.

[13]  J. Neu,et al.  Molecular Modulation of Intestinal Epithelial Barrier: Contribution of Microbiota , 2010, Journal of biomedicine & biotechnology.

[14]  Ruth E Ley,et al.  Obesity and the human microbiome , 2010, Current opinion in gastroenterology.

[15]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[16]  R. Ley,et al.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes , 2008, Nature.

[17]  V. Beral,et al.  Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study , 2008, BMJ : British Medical Journal.

[18]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[19]  J. Fox,et al.  T-cell function is critical for murine cholesterol gallstone formation. , 2007, Gastroenterology.

[20]  C. Rumio,et al.  Activation of Enteroendocrine Cells via TLRs Induces Hormone, Chemokine, and Defensin Secretion1 , 2007, The Journal of Immunology.

[21]  A. Ljungh,et al.  Lactic acid bacteria as probiotics. , 2006, Current issues in intestinal microbiology.

[22]  S. Gendler,et al.  Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. , 2006, Gastroenterology.

[23]  F. Lammert,et al.  Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43,141 twin pairs , 2005, Hepatology.

[24]  J. Fox,et al.  Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. , 2005, Gastroenterology.

[25]  Wolfgang Hoffmann,et al.  Independent Risk Factors for Gallstone Formation in a Region with High Cholelithiasis Prevalence , 2005, Digestion.

[26]  Yueming Ding,et al.  An efficient SNP system for mouse genome scanning and elucidating strain relationships. , 2004, Genome research.

[27]  S. Gendler,et al.  Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[28]  J. Fox,et al.  Spatial Distribution and Stability of the Eight Microbial Species of the Altered Schaedler Flora in the Mouse Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.

[29]  N. Afdhal,et al.  Genetic analysis of cholesterol gallstone formation: Searching for Lith (gallstone) genes , 2004, Current gastroenterology reports.

[30]  B. Paigen,et al.  Epidemiology of the American Indians' burden and its likely genetic origins , 2002, Hepatology.

[31]  F. Itoh,et al.  Mucins and Immune Reactions to Mucins in Ulcerative Colitis , 2001, Digestion.

[32]  T. Nash,et al.  The role of normal flora in Giardia lamblia infections in mice. , 2000, The Journal of infectious diseases.

[33]  F. Dewhirst,et al.  Phylogeny of the Defined Murine Microbiota: Altered Schaedler Flora , 1999, Applied and Environmental Microbiology.

[34]  B. Paigen,et al.  Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. , 1997, Journal of lipid research.

[35]  B. Paigen,et al.  Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Hofmann,et al.  Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. , 1978, Gastroenterology.

[37]  Stacey A. Jones Physiology of FGF15/19. , 2012, Advances in experimental medicine and biology.

[38]  T. Wang,et al.  Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.

[39]  G. Kullak-Ublick,et al.  Gallstone disease: Microlithiasis and sludge. , 2006, Best practice & research. Clinical gastroenterology.

[40]  G. Kullak-Ublick,et al.  Microlithiasis and sludge , 2006 .

[41]  W. Walker,et al.  Structure and function of intestinal mucin: developmental aspects. , 1987, International archives of allergy and applied immunology.

[42]  R. Michalides,et al.  Genetic differences in BALB/c sublines. , 1985, Current topics in microbiology and immunology.

[43]  M. Potter,et al.  History of the BALB/c family. , 1985, Current topics in microbiology and immunology.